Resilience Acquires Biologics Manufacturing Company Ology Bioservices
Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bio, based in Alachua, develops and manufactures drugs and biologics for commercial customers as well as the U.S. Department of Defense, with more than $1.8 billion in government contracts awarded. The acquisition provides Resilience with 300 skilled employees as well as more than 200,000 square feet of manufacturing, office, process development and quality assurance, and quality control space across locations in Florida, California, and Maryland, with additional expansion projects underway.
Read more about Resilience Acquires Biologics Manufacturing Company Ology Bioservices.